Cannabis hits new low in multiple sclerosis
This article was originally published in Scrip
Executive Summary
The first large non-commercial study to investigate whether the main active ingredient in cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS) has shown that there is no evidence to suggest this.